Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer
Biagio Ricciuti(Harvard University), Jia Luo(XinHua Hospital), Federica Pecci(University of Parma), Adam J. Schoenfeld(Memorial Sloan Kettering Cancer Center), Bijaya Sharma(Brigham and Women's Hospital), Chiara Ambrogio(Dana-Farber Cancer Institute), Marcelo V. Negrão(The University of Texas MD Anderson Cancer Center), Kristen D. Felt(Brigham and Women's Hospital), Tom Nguyen(Cho Ray Hospital), Andrew D. Cherniack(Broad Institute), Y Y Li(Dana-Farber Cancer Institute), Victor R. Vaz(Dana-Farber Cancer Institute), Arielle Elkrief(Centre Hospitalier de l’Université de Montréal), Kathryn C. Arbour(Memorial Sloan Kettering Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Ferdinandos Skoulidis(The University of Texas MD Anderson Cancer Center), Pasi A. Jänne(Harvard University), Matthew Meyerson(Broad Institute), Adriana P C Barrichello(Dana-Farber Cancer Institute), Scott J. Rodig(Brigham and Women's Hospital), David A. Barbie(Dana-Farber Cancer Institute), Alessio Cortellini(Campus Bio Medico University Hospital), James Lindsay, Jenny L. Zhang(The University of Texas MD Anderson Cancer Center), Mizuki Nishino(Brigham and Women's Hospital), Hersh Gupta(Dana-Farber Cancer Institute), Giuseppe Lamberti(Dana-Farber Cancer Institute), Joao V. Alessi(Hospital Sírio-Libanês), Mark M. Awad(Memorial Sloan Kettering Cancer Center), David J. Pinato(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Lynette M. Sholl(Brigham and Women's Hospital), Xinan Wang(Harvard University)
Cited by 100
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k